Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative C-Reactive Protein for Differentiation Between Tuberculous and Malignant Pleural Effusion: an Institutional Cross-Sectional Study

NCT06729931 is registered in ClinicalTrials.gov with Maharajgunj Medical Campus as lead sponsor.

NCT NCT06729931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06729931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative C-Reactive Protein for Differentiation Between Tuberculous and Malignant Pleural Effusion: an Institutional Cross-Sectional Study
Lead sponsor
Maharajgunj Medical Campus
Phase
Observational
Overall status
Completed
Start date
November 1, 2022
Completion date
December 15, 2023
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural effusions, pleural effusion, tuberculous pleural effusion